SGA
LXRX icon

Sector Gamma AS’s Lexicon Pharmaceuticals LXRX Stock Holding History

Sector Gamma AS’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-376,502
Closed -$2.09M – 35
2019
Q1 		$2.09M Sell
376,502
-486,100
-56% -$2.95M 0.34% 33
2018
Q4 		$5.73M Hold
862,602
– – 0.96% 27
2018
Q3 		$9.2M Hold
862,602
– – 1.44% 20
2018
Q2 		$10.4M Buy
862,602
+8,010
+0.9% +$81.9K 1.72% 18
2018
Q1 		$7.32M Buy
854,592
+17,400
+2% +$161K 1.32% 23
2017
Q4 		$8.27M Buy
837,192
+99,739
+14% +$1.04M 1.39% 25
2017
Q3 		$9.06M Buy
737,453
+114,798
+18% +$1.7M 1.38% 21
2017
Q2 		$10.2M Buy
622,655
+290,355
+87% +$4.5M 1.49% 21
2017
Q1 		$4.76M Buy
+332,300
New +$4.93M 0.76% 24

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Sector Gamma AS's LXRX Position: Q2 2019 in Review

Sector Gamma AS sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2019, closing a stake of 376,502 shares — an estimated $2.09M sold.

Sector Gamma AS first reported a position in LXRX in Q1 2017 and held it in 9 quarters. The position peaked at $10.4M in Q2 2018. 109 funds tracked by Wall St. Rank hold LXRX as of Q2 2019.

  • Sector Gamma AS reported no remaining Lexicon Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Sector Gamma AS sold 376,502 Lexicon Pharmaceuticals shares in Q2 2019, an estimated $2.09M.
  • Sector Gamma AS first reported a position in Lexicon Pharmaceuticals in Q1 2017 and held it in 9 quarters.
  • Sector Gamma AS's Lexicon Pharmaceuticals position peaked at $10.4M in Q2 2018.
  • 109 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2019.

Based on Sector Gamma AS's 13F filing for Q2 2019, filed 31 Jul 2019.